Researchers and “advocates for all vaccine research today launched yet another effort to increase funding and coordination,” ScienceInsider reports.
The GHI recently released its Guidance for Global Health Initiative Country Strategies. The guidance “defines and clarifies expectations about the GHI strategy,” “sets forth the parameters and content of a GHI strategy,” “provides guidance on how the field will structure itself to deliver on a key tenet of GHIâ€”adopting a…
Ahead of the U.N. High Level Meeting on AIDS, the Stop TB Partnership released five guidelines aimed at preventing tuberculosis, which results in one in four AIDS-related deaths, the U.N. News Centre writes.
In a New England Journal of Medicine opinion piece, Peter Hotez of the Sabin Vaccine Institute and colleagues, including Jeffrey Sachs of the Earth Institute of Columbia University, outline how integrating treatment of neglected tropical diseases (NTD) into HIV/AIDS, tuberculosis and malaria control efforts could speed up progress toward attaining the sixth Millennium Development Goal.
The May 26 issue of Nature explores vaccines, which the journal says “are responsible for some of the world’s greatest public health triumphs.” Though new vaccines for deadly diseases have been developed in the past 10 years, and more are in development, “funding is tight, and unfounded doubts about the safety of vaccines persist.” The issue features stories on polio, measles, HIV/AIDS, tuberculosis and malaria, as well as issues surrounding vaccine rejection and hysteria about risk (5/26).
IRIN examines tuberculosis among health care workers in Kenya, where “[s]afety equipment â€“ including protective masks and proper waste disposal facilities â€“ are rarely available in rural centres, something health workers say must be addressed urgently.”
“Health officials on Monday celebrated a faster treatment for people who have tuberculosis but aren’t infectious, after investigators found a new combination of pills knocks out the disease in three months instead of nine,” the Associated Press/Seattle Times reports (Stobbe, 5/16).
A wide variation in the dosages and forms of medicines prescribed by private physicians to patients with tuberculosis (TB) in developing countries could lead to the development of more drug-resistant strains of the bacterial infection, according to a study published online Wednesday in PLoS One, the Financial Times reports (Jack, 5/4).
Also In Global Health News: Libya Food Shortage; PMTCT In Swaziland; TB Detection In U.K.; Food Issues In Foreign Policy Magazine
Libya At Risk Of Serious Food Shortage Within Two Months, WFP Says Libya will run out of food within two months unless efforts are stepped up to get shipments into the war-torn country, the World Food Program (WFP) warned on Thursday, Deustche Presse-Agentur/M&C reports. Daly Belgasami, WFP’s director for the…
UNITAID Has Raised $2B Through Airline Tax Since 2006, Could Be Model For G20 Development Funding, UNITAID Chair Says
UNITAID, an international drug financing program established to help fight HIV/AIDS, tuberculosis and malaria in developing countries, has raised about $2 billion since 2006 through taxes on airline tickets in 15 countries, Philippe Douste-Blazy, chair of the UNITAID executive board, told reporters in Washington on Wednesday, Agence France-Presse reports. According to Douste-Blazy, UNITAID’s experience could provide a model for G20 development funding efforts.